Docosahexaenoic acid inhibits mechanical allodynia and thermal hyperalgesia in diabetic rats by decreasing the excitability of DRG neurons.
Diabetes mellitus is a common metabolic disease in human beings with characteristic symptoms of hyperglycemia, chronic inflammation and insulin resistance. One of the most common complications of early-onset diabetes mellitus is peripheral diabetic neuropathy, which is manifested either by loss of nociception or by allodynia and hyperalgesia. Dietary fatty acids, especially polyunsaturated fatty acids, have been shown the potential of anti-inflammation and modulating neuron excitability. The present study investigated the effects of docosahexaenoic acid (DHA) on the excitability of dorsal root ganglion (DRG) neurons in streptozotocin (STZ)-induced diabetes rats. The effects of DHA on the allodynia and hyperalgesia of diabetic rats were also evaluated. Dietary DHA supplementation effectively attenuated both allodynia and hyperalgesia induced by STZ injection. DHA supplementation decreased the excitability of DRG neurons by decreasing the sodium currents and increasing potassium currents, which may contribute to the effect of alleviating allodynia and hyperalgesia in diabetic rats. The results suggested that DHA might be useful as an adjuvant therapy for the prevention and treatment of painful diabetic neuropathy.
['Heng|Li-Jun|LJ|', 'Qi|Rui|R|', 'Yang|Rui-Hua|RH|', 'Xu|Guo-Zheng|GZ|']
D000200:Action Potentials D000818:Animals D003921:Diabetes Mellitus, Experimental D004195:Disease Models, Animal D004281:Docosahexaenoic Acids D005727:Ganglia, Spinal D006930:Hyperalgesia D007473:Ion Channels D008297:Male D009474:Neurons D010147:Pain Measurement D017288:Pain Threshold D018408:Patch-Clamp Techniques D051381:Rats D017207:Rats, Sprague-Dawley D026941:Sodium Channel Blockers D013311:Streptozocin D013779:Tetrodotoxin D013997:Time Factors
Docosahexaenoic acid Neuron excitability Dorsal root ganglion Painful diabetic neuropathy Potassium channel Sodium channel